JPRN-UMIN000008076已完成4 期
Clinical Performance of the Endeavor Zotarolimus-Eluting Stent in Real-world Japanese Patients: A Prospective Multicenter Registry - E-KANSAI Registry
Associations for Establishment of Evidence in Interventions0 个研究点目标入组 1,000 人开始时间: 2012年6月4日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Women known to be pregant or lactating mothers. 2. Known hypersensitivity or allergy to drugs including aspirin, heparin, clopidogrel, ticlopidine, and ABT- 578; rapamycin, tacrolimus, sirolimus, or their analogues, or other analogues/derivatives; or cobalt, chrome, nickel, molybdenum, or contrast media. 3. Life expectancy estimated to be less than 12 months. 4. Acute myocardial infarction (AMI) accompanied by cardiogenic shock. 5. Preexisting stents (drug-eluting stents [DES] or bare metal stents [BMS]) in the target vessel (stents in a branch of the target vessel do not preclude enrollment). 6. Patients known to have difficulty in continuing dual antiplatelet therapy (DAPT) because of a plan of other surgery after stenting.
研究者
相似试验
已完成
不适用
Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.Coronary Artery DiseaseNCT00609947Medtronic Vascular241
已完成
不适用
The Medtronic RESOLUTE US Clinical TrialCoronary Artery DiseaseNCT00726453Medtronic Vascular1,516
已完成
不适用
RESOLUTE China Registry:Ischemic Heart DiseaseStenotic Coronary LesionCardiovascular DiseasesArteriosclerosisCoronary Artery DiseaseNCT01243749Medtronic Vascular1,800
已完成
不适用
Evaluation of early clinical efficacy of azithromycin SR in treatment of acute pharyngotonsillitis and acute rhinosinusitisAcute pharyngotonsillitis Acute rhinosinusitisJPRN-UMIN000004743Wakayama-Okayama Otolaryngology Pharma300
已完成
不适用
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical StudyCoronary Artery DiseaseNCT02419521Medtronic Vascular75